World's Best Scientists 2026 revealed!

D-Index & Metrics

Economics and Finance

D-Index
41
Citations
6005
World Ranking
2208
National Ranking
263

Overview

Alan Haycox is affiliated with the University of Liverpool in the United Kingdom. Their research spans a combination of medicine and economics, with significant contributions in subfields such as pediatrics, perinatology and child health, economics and econometrics, pathology and forensic medicine, public health, environmental and occupational health, and neurology.

Their work covers a diverse range of topics including multiple sclerosis research studies, acute lymphoblastic leukemia research, CNS lymphoma diagnosis and treatment, health systems with a focus on economic evaluations and quality of life, pharmaceutical economics and policy, pharmaceutical studies and practices, as well as maternal and perinatal health interventions.

Recent publications reflect this interdisciplinary approach. Notable papers include:

  • "Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies," 2021, published in Multiple Sclerosis and Related Disorders
  • "The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour," 2021, published in BMC Research Notes

Haycox has collaborated frequently with several researchers in related fields, including Michael Levy, Ursula Becker, Cristina Costantino, Elisabetta Damonte, and Gaëlle Klingelschmitt. These collaborations align with the thematic concentration seen in Haycox's publications.

The scholar's works have appeared primarily in the following venues:

  • Multiple Sclerosis and Related Disorders
  • BMC Research Notes

Best Publications

  • Systematic review of cost effectiveness studies of telemedicine interventions.

    Pamela S Whitten;Frances S Mair;Alan Haycox;Carl R May

  • Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

    Jakub Adamski;Brian Godman;Brian Godman;Brian Godman;Gabriella Ofierska-Sujkowska;Bogusława Osińska

  • The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature

    Dyfrig A. Hughes;Adrian Bagust;Alan Haycox;Tom Walley

  • A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery

    Penny F Whiting;R Gupta;J Burch;R E Mujica Mota

  • Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

    Brian Godman;Björn Wettermark;Mikael Hoffmann;Karolina Andersson

  • Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

    Brian Barr Godman;Anna Bucsics;Patricia Vella Bonanno;Wija Oortwijn;Wija Oortwijn

  • Coronary artery stents: a rapid systematic review and economic evaluation

    R Hill;A Bagust;A Bakhai;R Dickson

  • Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation

    Y Dündar;A Boland;J Strobl;S Dodd

  • Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.

    Catherine Sermet;Veronique Andrieu;Brian Godman;Brian Godman;Brian Godman;Eric Van Ganse

  • The Iranian Health Insurance System; Past Experiences, Present Challenges And Future Strategies

    M Davari;A Haycox;T Walley

  • The implementation of managed entry agreements in Central and Eastern Europe : findings and implications

    Alessandra Ferrario;Diāna Arāja;Tomasz Bochenek;Tarik Čatić

  • Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

    Björn Wettermark;Björn Wettermark;Brian Godman;Karolina Andersson;Lars L. Gustafsson;Lars L. Gustafsson

  • Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

    Rickard E. Malmström;Brian B. Godman;Brian B. Godman;Brian B. Godman;Eduard Diogene;Christoph Baumgärtel

  • Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation

    A Boland;Y Dundar;A Bagust;A Haycox

  • A review of telemedicine cost-effectiveness studies:

    F S Mair;A Haycox;C May;T Williams

  • Clinical guidelines-the hidden costs.

    Alan Haycox;Adrian Bagust;Tom Walley

  • Accounting for Noncompliance in Pharmacoeconomic Evaluations

    Dyfrig A. Hughes;Adrian Bagust;Alan Haycox;Tom Walley

  • Enhancing the rational use of new medicines across European health care systems.

    Silvio Garattini;Vittorio Bertele;Brian Godman;Alan Haycox

  • Insight into recent reforms and initiatives in Austria: implications for key stakeholders

    Brian Godman;Anna Bucsics;Thomas Burkhardt;Alan Haycox

  • European countries with small populations can obtain low prices for drugs: Lithuania as a case history.

    Kristina Garuoliene;Brian Godman;Jolanta Gulbinovič;Björn Wettermark

  • The Health Economic Impact of Upper Gastrointestinal Symptoms in the General Population: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)

    A Haycox;T Einarson;A Eggleston

Frequent Co-Authors

Andrew Weeks
Andrew Weeks University of Liverpool
Carl May
Carl May London School of Hygiene & Tropical Medicine
Anna Maria Geretti
Anna Maria Geretti University of Liverpool
Scott M. Hofer
Scott M. Hofer University of Victoria
Ruth McDonald
Ruth McDonald University of Manchester
Keith S. Wilson
Keith S. Wilson University of York
Geraint Johnes
Geraint Johnes Lancaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Economics and Finance, exploring related online degrees can open new doors for career advancement. Specialized programs like online masters programs in project management provide essential skills in planning, leadership, and strategic thinking, all highly valued in today’s business landscape.

Fast-tracked education is also gaining popularity. One-year MBA programs allow professionals to rapidly gain management expertise without a multi-year commitment. For those with an entrepreneurial mindset, choosing the cheapest MBA entrepreneurship online program can help develop business ideas while managing costs effectively.

Even at the undergraduate level, degrees like a Bachelor in Project Management are increasingly relevant. But students often wonder, is a bachelor degree in project management worth it? The answer depends on your career goals and the demand for strategic project leaders, which continues to grow across industries.

By choosing the right online pathway, you can tailor your studies to rapidly changing market needs and broaden your professional opportunities in finance, management, and entrepreneurship.

Best Scientists Citing Alan Haycox

Trending Scientists

Recently Published Articles